17 results · 31ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

AMICO DH-W35 OPHTHALMOSCOPE SERIES

FDA 510(k)
FDA Class 2 ·Ophthalmic

Bernafon

FDA UDI
Bernafon AG·05711584050309·PC7 CPX, VC PS GB PRECISO 7

BIO-EUROLIG INTERFERENCE SCREW

FDA 510(k)
FDA Class 2 ·Orthopedic

OSTEOBRIDGE IKA INTRAMEDULLARY KNEE ARTHRODESIS ROD FIXATION SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

RECEPTAL CANISTER 1000 ML CE

FDA Adverse Event
Malfunction ·AMSINO MEDICAL CO., LTD.·Product code GCX·May 25, 2012

RECEPTAL 1.5LITER PE/CE WITH (50/CASE)

FDA Adverse Event
Malfunction ·HOSPIRA LTD.·Product code GCX·August 1, 2011

NON-PVC RECEPT LINER 2000ML/CE(50/CS)

FDA Adverse Event
Malfunction ·HOSPIRA, LTD.·Product code GCX·June 21, 2011

NON-PVC RECEPT. LINER 2000ML/CE(50/CS)

FDA Adverse Event
Malfunction ·HOSPIRA, LTD.·Product code GCX·June 21, 2011

NON-PVC RECEPT LINER 2000ML/CE(50/CS)

FDA Adverse Event
Malfunction ·HOSPIRA, LTD.·Product code GCX·June 21, 2011

RECEPTAL 1.5 LITER PE/CE WITH (50/CASE)

FDA Adverse Event
Injury ·HOSPIRA LTD.·Product code GCX·November 18, 2010

RECEPTAL 1 LITER/CE WITH VALVE (50/CAS)

FDA Adverse Event
Malfunction ·HOSPIRA LTD.·Product code GCX·June 24, 2011

RECEPTAL 1 LITER/CE WITH VALVE (50/CAS)

FDA Adverse Event
Malfunction ·HOSPIRA LTD.·Product code GCX·June 24, 2011

DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·October 29, 2018

ALTRX +4 10D 32IDX50OD

FDA Adverse Event
Injury ·1818910 DEPUY ORTHOPAEDICS, INC.·Product code LPH·May 29, 2013

VERSA DR

FDA Adverse Event
Injury ·MEDTRONIC MED REL, INC.·Product code NVZ·June 16, 2011

DEXTRUS 4136

FDA Adverse Event
Injury ·BIOTRONIK GMBH AND CO.·Product code DTB·August 21, 2008

Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled selective infusion of physician-specified therapeutics agents such as embolization materials and of diagnostic materials such as contrast media. UltraFlow HPC Flow: The device is intended for the controlled selective infusion of physician-specified pharmacologic agents or contrast media into the distal vasculature of the peripheral and neuroanatomy. It is not intended for use in the coronary vasculature. Catalog No. 105-5055V02 105-5055V02 105-5055V05 105-5065V02 105-5065V05 105-5066V02 105-5066V05

FDA Enforcement
Class I ·Terminated·Micro Therapeutics Inc, Dba Ev3 Neurovascular·November 16, 2016